TrialThe Lancet. Oncology2016

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.

Howard L Kaufman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.